About Genome Compiler Corporation
Genome Compiler Corporation is a Healthcare company based in Tel Aviv (Israel) founded in 2011 by Omri Amirav-Drory, and was acquired by Twist Bioscience in April 2016. DNA design, visualization, data management, and collaboration tools are provided. Genome Compiler Corporation has raised $5 million across 4 funding rounds from investors including Autodesk, Twist Bioscience and NFX. Its chief executive, as recorded, is Omri Amirav-Drory. The company was acqui-hired. Genome Compiler Corporation offers products and services including Alternative Link Service. Its focus areas include Life Sciences, Genomics, Genome Informatics and Integrative Bioinformatics Platforms.
Company details
A software platform is offered by Genome Compiler Corporation to support genetic engineers and synthetic biologists in DNA design, visualization, data management, and collaboration. Tools for plasmids and parts repositories, connections to DNA synthesis providers, and lab automation services are included to facilitate combinatorial project designs. The company was founded in 2011 and operates from locations in Tel Aviv, Israel, and Los Altos, California.
- Headquarters Tel Aviv, Israel
- Founders Omri Amirav-Drory
- Stage Acquired
- SectorsHealthcare
- Website genomecompiler.com
- Social LinkedIn X Facebook
- Acquired by Twist Bioscience (Apr 2016)
- Total Equity Funding$5M (USD)
in 4 rounds
- InvestorsAutodesk
& 3 more
- Acquired byTwist Bioscience
(Apr 2016)
Products & Services of Genome Compiler Corporation
Genome Compiler Corporation offers a comprehensive portfolio of products and services, including Alternative Link Service.
Provides secure links for online registration and login
Funding Insights of Genome Compiler Corporation
Genome Compiler Corporation has successfully raised a total of $5M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 4
- First Round $3M
(Jun 2011)
- Investors Count 3
All 4 funding rounds of Genome Compiler Corporation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Genome Compiler Corporation
Genome Compiler Corporation has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Autodesk, Twist Bioscience and NFX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering funding and tools for startups in technology and investment sectors. | nfx.com | |||
Provider of cloud-based 3D CAD modeling software for the AEC industry | 1982 | autodesk.com | San Francisco, United States | |
Delivers comprehensive e-commerce support services to businesses. | 1899 | fjwestcott.com | Maumee, United States | |
Synthetic DNA is synthesized via a semiconductor-based platform. | 2013 | twistbioscience.com | San Francisco, United States |
Investor details for Genome Compiler Corporation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genome Compiler Corporation
319 people are tracked at Genome Compiler Corporation (56 in leadership, 6 in board & advisors, 257 in team).
| Name | Role | Group |
|---|---|---|
Omri Amirav-Drory | Founder & CEO | Leadership |
Dennis Cho | Chief Legal Officer & Corporate Secretary | Leadership |
Tom Asher | Vp, Global Support | Leadership |
Lukas Burlingis | Vp, Corporate Controller | Leadership |
Austin Hsiao | Senior Director, Systems Engineering | Leadership |
Angela Bitting | Chief ESG Officer & SVP, Corporate Affairs | Leadership |
Irene Hoang | Senior Director Of Technology Operations | Leadership |
Siyuan Chen | Chief Technology Officer | Leadership |
Leslie Stanton | Vp, Operations Technology Group, Data Systems | Leadership |
Emily Leproust | Chief Executive Officer | Leadership |
Garry Merry | Executive Director Commercial Operations | Leadership |
Sasank P. | Director, Business Systems | Leadership |
John H. | Director, Human Resource Business Partner | Leadership |
Nara Ramakrishnan | Senior Director Information Technology | Leadership |
Bryan N. Höglund | Director of Applications & Business Development, NGS | Leadership |
Jeremy Dumsday | Sales Director- Kosea | Leadership |
Jimmy Jin | Vice President, Product Management & Marketing | Leadership |
Christina Littler | Senior Director, NGS Product Management | Leadership |
Chris T. | Director of Digital Marketing | Leadership |
Annarose Bednarz | Talent Acquisition Business Partner | Leadership |
299 more people are available in the full profile.
Complete people profiles for Genome Compiler Corporation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genome Compiler Corporation
4 dated milestones of Genome Compiler Corporation across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Genome Compiler Corporation is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series A,.
- Exit Acquired by Twist Bioscience.
Web traffic of Genome Compiler Corporation
Websites that share an audience with Genome Compiler Corporation (genomecompiler.com).
Websites whose visitors overlap most with Genome Compiler Corporation. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
glowingplant.com | glowingplant.com | 100% | – | ||
getsynbio.com | getsynbio.com | 92% | – | ||
dna20.com | dna20.com | 92% | – | ||
| synbiobeta.com | 90% | #979,192 | View details | ||
| openwetware.org | 89% | #2,027,372 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Genome Compiler Corporation
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genome Compiler Corporation
Complete news archive for Genome Compiler Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genome Compiler Corporation
Genome Compiler Corporation was founded in 2011.
Genome Compiler Corporation is headquartered in Tel Aviv, Israel.
Omri Amirav-Drory is the CEO of Genome Compiler Corporation, as recorded in our data. They have also founded this company.
Genome Compiler Corporation is a funded company, having raised a total of $5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Jun 2011.
A software platform is offered by Genome Compiler Corporation to support genetic engineers and synthetic biologists in DNA design, visualization, data management, and collaboration. Tools for plasmids and parts repositories, connections to DNA synthesis providers, and lab automation services are included to facilitate combinatorial project designs. The company was founded in 2011 and operates from locations in Tel Aviv, Israel, and Los Altos, California.
Genome Compiler Corporation offers Alternative Link Service.
Genome Compiler Corporation has 4 investors. Key investors include Autodesk, Twist Bioscience, NFX, and Westcott.
Yes. Genome Compiler Corporation was acquired by Twist Bioscience in April 2016.